Wells Fargo Maintains Equal-Weight on Globus Medical, Raises Price Target to $63
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Vik Chopra maintains an Equal-Weight rating on Globus Medical (NYSE:GMED) and raises the price target from $61 to $63.
August 04, 2023 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo maintains an Equal-Weight rating on Globus Medical and raises the price target from $61 to $63, which could potentially lead to a positive market reaction.
The raised price target by Wells Fargo indicates a positive outlook for Globus Medical. This could potentially lead to a positive market reaction as it suggests that the stock is undervalued at its current price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100